← back to search

Mark E. Anderson

University of Central Florida · US
Area of research
Cardiology and Cardiovascular Medicine · Molecular Biology
Research interest
Research interests include Cardiac electrophysiology and arrhythmias, Ion channel regulation and function, Cardiomyopathy and Myosin Studies, and Neuroscience and Neuropharmacology Research.
h-index
85
citations
22,692
works
471
NIH funding
primary concept
Medicine
email

Recent publications

HCN4 channels sense temperature and determine heart rate responses to heat.
2025cited by 2position: contributordoi
An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor
Science Translational Medicine 2023cited by 58position: lastdoi
An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor.
2023cited by 48position: contributordoi
Genome-wide CRISPR screen reveals genetic modifiers of Ca <sup>2+</sup> -mediated cell death
2023cited by 0position: contributordoi
CaMKII as a Therapeutic Target in Cardiovascular Disease
The Annual Review of Pharmacology and Toxicology 2022cited by 125position: lastdoi
Heart Failure and Atrial Fibrillation-Chicken or Egg?
2022cited by 6position: contributordoi
Excessive <i>O</i> -GlcNAcylation Causes Heart Failure and Sudden Death
Circulation 2021cited by 129position: lastdoi
Excessive <i>O</i> -GlcNAcylation Causes Heart Failure and Sudden Death
Circulation 2021cited by 127position: contributordoi
CaMKII oxidation is a critical performance/disease trade-off acquired at the dawn of vertebrate evolution.
2021cited by 30position: contributordoi
PDE1 Inhibition Modulates Ca&lt;sub&gt;v&lt;/sub&gt;1.2 Channel to Stimulate Cardiomyocyte Contraction.
2021cited by 20position: contributordoi
Loss of CASK Accelerates Heart Failure Development.
2021cited by 15position: contributordoi
Totally Rad? The Long and Winding Road to Understanding Ca <sub>V</sub> 1.2 Regulation
Circulation Research 2021cited by 2position: contributordoi
Voices for Social Justice and Against Racism: An AAIM Perspective
The American Journal of Medicine 2021cited by 1position: contributordoi
Boost US federal funding for international trainees.
2021cited by 0position: contributordoi
Mitochondrial CaMKII causes adverse metabolic reprogramming and dilated cardiomyopathy
Nature Communications 2020cited by 88position: lastdoi
Mitochondrial CaMKII causes adverse metabolic reprogramming and dilated cardiomyopathy.
2020cited by 77position: contributordoi
MICAL1 constrains cardiac stress responses and protects against disease by oxidizing CaMKII
Journal of Clinical Investigation 2020cited by 41position: lastdoi
PDE1 inhibition modulates Ca<sub>v</sub>1.2 channel to stimulate cardiomyocyte contraction
2020cited by 0position: contributordoi
Chronic Calmodulin-Kinase II Activation Drives Disease Progression in Mutation-Specific Hypertrophic Cardiomyopathy
Circulation 2019cited by 42position: middledoi
E-C coupling structural protein junctophilin-2 encodes a stress-adaptive transcription regulator
Science 2018cited by 112position: middledoi
Inhibition of MCU forces extramitochondrial adaptations governing physiological and pathological stress responses in heart
Proceedings of the National Academy of Sciences 2015cited by 161position: lastdoi
The mitochondrial uniporter controls fight or flight heart rate increases
Nature Communications 2015cited by 147position: lastdoi
Microtubule-Mediated Defects in Junctophilin-2 Trafficking Contribute to Myocyte Transverse-Tubule Remodeling and Ca <sup>2+</sup> Handling Dysfunction in Heart Failure
Circulation 2014cited by 143position: middledoi
Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9–10, 2013
Heart Rhythm 2014cited by 95position: middledoi
Oxidized Ca <sup>2+</sup> /Calmodulin-Dependent Protein Kinase II Triggers Atrial Fibrillation
Circulation 2013cited by 312position: lastdoi
Ionizing radiation regulates cardiac Ca handling via increased ROS and activated CaMKII
Basic Research in Cardiology 2013cited by 48position: middledoi
Phosphoproteomics Study Based on In Vivo Inhibition Reveals Sites of Calmodulin‐Dependent Protein Kinase II Regulation in the Heart
Journal of the American Heart Association 2013cited by 23position: middledoi
CaMKII effects on inotropic but not lusitropic force frequency responses require phospholamban
Journal of Molecular and Cellular Cardiology 2012cited by 22position: lastdoi

Grants

Research Experiences for Undergraduates in Chemistry at Virginia Tech
NSF0244068$211,4102003–2007PIRePORTER

Frequent collaborators

· 13 papers (2020–2025)Elizabeth D. Luczak · MACOM (United States)8 papers (2012–2023) · 6 papers (2020–2025)Biyi Chen · University of Iowa5 papers (2013–2018)Xander H.T. Wehrens · Baylor College of Medicine5 papers (2012–2023)Long‐Sheng Song · University of Iowa5 papers (2013–2018)Robert M. Weiss · University of Iowa4 papers (2013–2018) · 4 papers (2020–2023)Mei-ling A. Joiner · University of Iowa4 papers (2013–2020)Yuejin Wu · Johns Hopkins Medicine4 papers (2015–2021)Oscar E. Reyes Gaido · Brigham and Women's Hospital4 papers (2020–2023)Olurotimi Mesubi · Johns Hopkins Hospital3 papers (2021–2023)Liliana Florea · Johns Hopkins University3 papers (2021–2021)Olha M. Koval · ABB (United States)3 papers (2013–2015)Jonathan Granger · Yale University3 papers (2020–2023)Priya Umapathi · University of Baltimore3 papers (2020–2022)Qinchuan Wang · Zhejiang University3 papers (2015–2022)Thomas Sowa · University Hospital Regensburg2 papers (2013–2013)Albert J. R. Heck · Utrecht University2 papers (2013–2020)Duane D. Hall · University of Iowa2 papers (2015–2018)